欢迎访问《现代生物医学进展》编辑部！

目的：探讨冠心病患者静息心率与血小板活性的相关研究。方法：选择2013 年1 月至2014 年9 月于我院住院患者474 例，按静息心率快慢分为三组，心率<70 bmp 为第一组(Q1)150 例，心率位于70~85 bmp 为第二组(Q2)265 例，心率>85 bmp 为第三组 (Q3)59 例，三组患者均于病情稳定时行血栓弹力图(TEG)中MA 值检测，同时随访3 个月，观察和比较三组患者MA 值变化及预后。结果：三组患者MA 值分别为61.16± 7.29 mm、62.02± 7.46 mm、65.32± 6.56 mm，第三组患者MA 值与第一组或第二组患者 MA 值比较差异均存在统计学意义(P<0.05)，通过血栓弹力图检测三组经花生四烯酸(AA)途径的血小板抑制率和经二磷酸腺苷 (ADP)途径的血小板抑制率发现，静息心率高低与抗血小板药物作用疗效无相关关系(P>0.05)。随访3 个月，三组患者心绞痛、再住院、脑血管病及死亡的总发生率分别为28 %、28.68 %、40.67 %。结论：冠心病患者静息心率越快，MA 值越大即血小板活性越高，静息心率的高低与抗血小板药物作用疗效无关。

英文摘要:

Objective:To analyze the relationship between resting heart rate and platelet activity in patients with coronary heart disease.Methods:474 cases of patients with coronary heart disease admitted in our hospital from January 2013 to September 2014 were selected for this study. There were 150 cases of patients' resting heart rate lower than 70 bmp (Q1 group), and 265 cases of patients' resting heart rate between 70 bmp and 85 bmp (Q2 group), and 59 higher than 85bmp (Q2 group). All the patients were detected MA value in thrombelastography (TEG), and followed up for 3 months. The MA value and prognosis were compared among three groups.Results:The MA value of three groups were 61.16± 7.29 mm, 62.02± 7.46 mm, 65.32± 6.56 mm. There were significant differences between Q1 and Q3, and between Q2 and Q3 (P<0.05). Through ADP and AA pathway, the effect of antiplatelet agents were observed and compared among the three groups, the results showed that resting heart rate was not related with the effect of antiplatelet agents. After 3 months, follow-up, the total incidence of adverse events including angina, rehospitalization, cerebrovascular disease and death were 28 %, 28.68 %, and 40.67 % in the three groups, respectively.Conclusion:The patients of coronary heart disease with the faster resting heart rate had the greater MA value, which meant the higher platelet activity, and the level of resting heart rate was not related with the effect of antiplatelet agents.

查看全文查看/发表评论下载PDF阅读器

关闭